Hemophilia B is a severe X-linked bleeding diathesis caused by the absence of functional blood coagulation factor IX, and is an excellent candidate for treatment of a genetic disease by gene therapy.
Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: 4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA) ...
Northern Shield Resources Inc. ("Northern Shield" or the "Company") is pleased to announce the results of the summer's drilling at the Conquest Zone and ongoing field work on the Creston Copper Target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback